[1]
D. Vordermark, “3-D conformal treatment of prostate cancer to 74 Gy vs. high-dose-rate brachytherapy boost: A cross-sectional quality-of-life survey”, AO, vol. 45, no. 6, pp. 708–716, Jan. 2006.